Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
暂无分享,去创建一个
A. Camm | P. Kirchhof | G. Lip | U. Schotten | I. Savelieva | S. Ernst | I. V. Van Gelder | N. Al-Attar | G. Hindricks | B. Prendergast | H. Heidbuchel | O. Alfieri | A. Angelini | D. Atar | P. Colonna | R. de Caterina | J. De Sutter | A. Goette | B. Gorenek | M. Heldal | Stefan H. Hohloser | P. Kolh | J. Le Heuzey | P. Ponikowski | F. Rutten
[1] D. Serr,et al. PROPRANOLOL FOR THE TREATMENT OF HYPERTENSION IN PREGNANCY , 1978, British journal of obstetrics and gynaecology.
[2] G. Klein,et al. Acceleration of the Ventricular Response During Atrial Fibrillation in the Wolff‐Parkinson‐White Syndrome After Verapamil , 1982, Circulation.
[3] R. Coleman,et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. , 1986, The American journal of cardiology.
[4] L. E. Peterson,et al. Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. , 1988, European heart journal.
[5] I. V. Van Gelder,et al. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.
[6] H L Greene,et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.
[7] J. Boineau,et al. Successful surgical treatment of atrial fibrillation. Review and clinical update. , 1991, JAMA.
[8] J. Cox,et al. Successful surgical treatment for atrial fibrillation , 1992 .
[9] P C Deedwania,et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.
[10] M. Chang,et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. , 1995, European heart journal.
[11] F. Morady,et al. Effect of atrial fibrillation on atrial refractoriness in humans. , 1996, Circulation.
[12] Amit Kumar. Intravenous Amiodarone for Therapy of Atrial Fibrillation and Flutter in Critically Ill Patients With Severely Depressed Left Ventricular Function , 1996, Southern medical journal.
[13] M. Santini,et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. , 1996, Journal of the American College of Cardiology.
[14] M. Russo,et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.
[15] K. Ellenbogen,et al. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. , 1997, Circulation.
[16] G. Lip,et al. Original Papers , 2016 .
[17] P C Deedwania,et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. , 1998, Circulation.
[18] J Clémenty,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.
[19] F. Morady,et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. , 1999, The New England journal of medicine.
[20] S. Connolly. Evidence-based analysis of amiodarone efficacy and safety. , 1999, Circulation.
[21] Bramahn . Singh,et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.
[22] A. Camm,et al. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation. , 1999, Circulation.
[23] Management of new onset atrial fibrillation. , 2000, Evidence report/technology assessment.
[24] A. Goette,et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.
[25] M. Santini,et al. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. , 2000, European heart journal.
[26] A. Aggarwal. Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.
[27] C Antzelevitch,et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. , 2000, European heart journal.
[28] Marlene R. Miller,et al. The evidence regarding the drugs used for ventricular rate control. , 2000, The Journal of family practice.
[29] P. Vardas,et al. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study. , 2000, Chest.
[30] S. Hohnloser,et al. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial , 2000, The Lancet.
[31] F. Martínez-Marcos,et al. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. , 2000, The American journal of cardiology.
[32] J. McMurray,et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study , 2001, Heart.
[33] M. Rich,et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.
[34] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[35] I. Khan. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2001, Journal of the American College of Cardiology.
[36] B. Gersh,et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. , 2001, The New England journal of medicine.
[37] Simon Stewart,et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.
[38] E. Bernal,et al. Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.
[39] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[41] B. Maron,et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[42] G. Breithardt,et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial , 2002, The Lancet.
[43] H. Crijns,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .
[44] J. Brugada,et al. Long-lasting sport practice and lone atrial fibrillation. , 2002, European heart journal.
[45] H. Crijns,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.
[46] J. Cleland,et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? , 2003, Journal of the American College of Cardiology.
[47] Yuchiao Chang,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.
[48] U. Tebbe,et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.
[49] V. Santinelli,et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. , 2003, The New England journal of medicine.
[50] Ying Wang,et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. , 2003, Science.
[51] Haran Burri,et al. Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. , 2003, Journal of the American College of Cardiology.
[52] M. Bulsara,et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). , 2003, Journal of the American College of Cardiology.
[53] Silvia G Priori,et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.
[54] Silvia G Priori,et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.
[55] Stefan Kääb,et al. Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol. , 2003, European heart journal.
[56] Temporary Atrial Epicardial Pacing as Prophylaxis Against Atrial Fibrillation after Heart Surgery: , 2003, Journal of cardiovascular electrophysiology.
[57] Yuchiao Chang,et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.
[58] Wen-Chung Yu,et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. , 2003, European heart journal.
[59] Ralph B D'Agostino,et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. , 2004, JAMA.
[60] N. Smedira,et al. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.
[61] Theodor Landis,et al. Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter After Acute Stroke and Transient Ischemic Attack , 2004, Stroke.
[62] G. Heinze,et al. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. , 2004, European heart journal.
[63] Prashanthan Sanders,et al. Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.
[64] P. Alboni,et al. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. , 2004, The New England journal of medicine.
[65] G. Breithardt,et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. , 2004, European heart journal.
[66] E. Daoud. Management of atrial fibrillation in the post-cardiac surgery setting. , 2004, Cardiology clinics.
[67] A. Torbicki,et al. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. , 2004, Chest.
[68] J. Mathew,et al. A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004, JAMA.
[69] D. Levy,et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.
[70] P. Vardas,et al. Effects of Amiodarone and Diltiazem on Persistent Atrial Fibrillation Conversion and Recurrence Rates: A Randomized Controlled Study , 2004, Cardiovascular Drugs and Therapy.
[71] S. Yusuf,et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. , 2004, The Cochrane database of systematic reviews.
[72] H. Crijns,et al. Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: A randomized, double-blind study , 1996, Cardiovascular Drugs and Therapy.
[73] C. Israel,et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. , 2004, Journal of the American College of Cardiology.
[74] S. Yusuf,et al. Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .
[75] D. Shah,et al. Linear Cryoablation of the Left Atrium Versus Pulmonary Vein Cryoisolation in Patients With Permanent Atrial Fibrillation and Valvular Heart Disease: Correlation of Electroanatomic Mapping and Long-Term Clinical Results , 2005, Circulation.
[76] S. Connolly,et al. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis , 2005, Heart.
[77] Christopher Piorkowski,et al. Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.
[78] Mandeep Bhargava,et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.
[79] D. Reda,et al. Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.
[80] C. Fowler,et al. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia. , 2005, Health technology assessment.
[81] H. Wellens. When to Perform Catheter Ablation in Asymptomatic Patients With a Wolff-Parkinson-White Electrocardiogram , 2005, Circulation.
[82] A. Skanes,et al. Use of medications in Wolff-Parkinson-White syndrome , 2005, Expert opinion on pharmacotherapy.
[83] J Raftery,et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. , 2005, Health technology assessment.
[84] M. Nieminen,et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.
[86] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[87] Douglas Packer,et al. Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation.
[88] Jeffrey L. Anderson,et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.
[89] Dietrich Andresen,et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. , 2005, European heart journal.
[90] Gregory Y H Lip,et al. Quality of life in patients with atrial fibrillation: a systematic review. , 2006, The American journal of medicine.
[91] Stephen S. Cha,et al. Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.
[92] S. Mohiuddin,et al. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. , 2006, American heart journal.
[93] S. Bagshaw,et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. , 2006, The Annals of thoracic surgery.
[94] Rahul Mehra,et al. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. , 2006, Heart rhythm.
[95] D. Singer,et al. Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation Study , 2006, Journal of the American Geriatrics Society.
[96] Jun Dong,et al. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. , 2006, European heart journal.
[97] Pietro Delise,et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[98] A. Keech,et al. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. , 2006, European heart journal.
[99] M. Pfeffer,et al. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, American heart journal.
[100] A. Hofman,et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.
[101] F. Van de Werf,et al. Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter. , 2006, International journal of cardiology.
[102] M. Pfeffer,et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.
[103] V. Santinelli,et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.
[104] J. Dunning,et al. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[105] C. White,et al. Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[106] M. Pfeffer,et al. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. , 2006, American heart journal.
[107] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[108] V. Pasceri,et al. Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study , 2006, Circulation.
[109] Kiyoshi Yoshida,et al. Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. , 2006, Stroke.
[110] J. Copeland,et al. Amiodarone Prophylaxis for Atrial Fibrillation After Cardiac Surgery: Meta‐Analysis of Dose Response and Timing of Initiation , 2007, Pharmacotherapy.
[111] J. Ruskin,et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.
[112] B. Gersh,et al. Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study , 2007, Circulation.
[113] D. Ngaage,et al. Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified? , 2007, The Annals of thoracic surgery.
[114] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[115] A. Tveit,et al. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. , 2007, The American journal of cardiology.
[116] Bertil Olsson,et al. Outcome parameters for trials in atrial fibrillation: executive summary. , 2007, European heart journal.
[117] J. Ruskin,et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.
[118] J. Le Heuzey,et al. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. , 2007, European heart journal.
[119] J. Camm,et al. Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation? , 2007, American heart journal.
[120] M. Metra,et al. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. , 2007, The American journal of cardiology.
[121] Helmut Baumgartner,et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .
[122] G. Lip,et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial , 2007, The Lancet.
[123] S. Mouly,et al. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. , 2007, The Cochrane database of systematic reviews.
[124] David A Fitzmaurice,et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial , 2007, BMJ : British Medical Journal.
[125] E. Aliot,et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. , 2007, The New England journal of medicine.
[126] M. de Andrade,et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. , 2008, The New England journal of medicine.
[127] E. Aliot,et al. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[128] John V. Wylie,et al. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. , 2008, Archives of internal medicine.
[129] A. Camm,et al. Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation: A Phase 3, Randomized, Placebo-Controlled Trial , 2008, Circulation.
[130] A. Camm,et al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .
[131] A. Zanchetti,et al. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial , 2008, Journal of hypertension.
[132] Perry M. Elliott,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[133] G. Lip,et al. Consensus document on antithrombotic therapy in the setting of electrophysiological procedures. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[134] A. Raviele,et al. Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials. , 2008, Journal of atrial fibrillation.
[135] J. Davy,et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. , 2008, American heart journal.
[136] F. Sacher,et al. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study , 2008, Circulation.
[137] Gregory Y H Lip,et al. Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data , 2008, Thrombosis and Haemostasis.
[138] Curt D. Furberg,et al. Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study , 2008, Circulation.
[139] D. Wyse,et al. Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation , 2009, Journal of Interventional Cardiac Electrophysiology.
[140] Michael Böhm,et al. Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.
[141] Tong Liu,et al. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. , 2008, International journal of cardiology.
[142] G. Breithardt,et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. , 2008, European heart journal.
[143] J. Camm,et al. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation , 2008, Nature Clinical Practice Cardiovascular Medicine.
[144] M. Metra,et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation , 2008, European heart journal.
[145] David O. Martin,et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.
[146] A. Gillinov,et al. Surgical approaches for atrial fibrillation. , 2008, The Medical clinics of North America.
[147] J. McMurray,et al. Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.
[148] L. Fauchier,et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. , 2008, Journal of the American College of Cardiology.
[149] J. Molnar,et al. Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis , 2008, American journal of therapeutics.
[150] J. Hirsh,et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[151] D. Singer,et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[152] Jagmeet P. Singh,et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. , 2008, Journal of the American College of Cardiology.
[153] S. Mittal,et al. Long‐Term Outcome Following Successful Pulmonary Vein Isolation: Pattern and Prediction of Very Late Recurrence , 2008, Journal of cardiovascular electrophysiology.
[154] S. Hohnloser,et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. , 2009, European heart journal.
[155] E. Aliot,et al. Indications for the use of diagnostic implantable and external ECG loop recorders. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[156] A. Goette,et al. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles , 2009, European heart journal.
[157] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[158] M. Hirai,et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[159] Douglas Packer,et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. , 2009, Journal of the American College of Cardiology.
[160] Matthew R. Reynolds,et al. Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses , 2009, Circulation. Arrhythmia and electrophysiology.
[161] Salim Yusuf,et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[162] Maurice Buchbinder,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.
[163] S. Perlini,et al. Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients. , 2009, Journal of the American College of Cardiology.
[164] I. Savelieva,et al. Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.
[165] E. Toft,et al. Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial , 2009, Circulation. Arrhythmia and electrophysiology.
[166] A. Skanes,et al. Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale , 2009, Circulation. Arrhythmia and electrophysiology.
[167] Paulus Kirchhof,et al. Can we improve outcomes in AF patients by early therapy? , 2009, BMC medicine.
[168] N. Freemantle,et al. Morbidity and Mortality Associated With Anti-Arrhythmic Drugs in Atrial Fibrillation: A Systematic Review and Mixed Treatment Meta-Analysis , 2009 .
[169] G. Wassmer,et al. Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review. , 2009, The Journal of thoracic and cardiovascular surgery.
[170] T. Arora,et al. Reversal of propoxur-induced impairment of memory and oxidative stress by 4′-chlorodiazepam in rats , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.
[171] P. Kirchhof,et al. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. , 2009, Journal of the American College of Cardiology.
[172] F. Regoli,et al. Cardiac resynchronization therapy in heart failure patients with atrial fibrillation , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[173] G. Breithardt,et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[174] Stephan Willems,et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. , 2009, European heart journal.
[175] J. Healey,et al. A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation , 2009, Journal of cardiovascular electrophysiology.
[176] C. Gieger,et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke , 2009, Nature Genetics.
[177] Timothy Watson,et al. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.
[178] G. Naccarelli,et al. Increasing prevalence of atrial fibrillation and flutter in the United States. , 2009, The American journal of cardiology.
[179] A. Rigby,et al. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFÉ-II Study) , 2009, Heart.
[180] Nancy R Cook,et al. Relation of vigorous exercise to risk of atrial fibrillation. , 2009, The American journal of cardiology.
[181] A. Maggioni,et al. Valsartan for prevention of recurrent atrial fibrillation. , 2009, The New England journal of medicine.
[182] S. Connolly,et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.
[183] V. Hasselblad,et al. Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized, Controlled Trials , 2009, Circulation. Arrhythmia and electrophysiology.
[184] K. Ho,et al. Benefits and Risks of Corticosteroid Prophylaxis in Adult Cardiac Surgery: A Dose-Response Meta-Analysis , 2009, Circulation.
[185] M. Rosenqvist,et al. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study. , 2008, European heart journal.
[186] G. Lip,et al. Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort , 2010, Stroke.
[187] J. Sturdivant,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2010 .
[188] R. Vest. Comparative Efficacy of Dronedarone and Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation , 2010 .
[189] Jeroen J. Bax,et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery , 2009 .
[190] D. Arnar,et al. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[191] M. Böhm,et al. Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition , 2010 .
[192] J. Le Heuzey,et al. A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study , 2010, Journal of cardiovascular electrophysiology.
[193] P. Kirchhof,et al. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting , 2009, Thrombosis and Haemostasis.
[194] Otto Kamp,et al. Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.
[195] Burr Hall,et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.
[196] S. Kaul,et al. Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium? , 2010, Journal of the American College of Cardiology.
[197] S. Connolly,et al. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. , 2010, Journal of the American College of Cardiology.
[198] W. W. Brabham. Valsartan for Prevention of Recurrent Atrial Fibrillation , 2010 .
[199] M. Cheitlin. Comparison of Beta Blocker and Digoxin Alone and in Combination for Management of Patients With Atrial Fibrillation and Heart Failure , 2010 .
[200] Jeroen J. Bax,et al. Prediction of atrial fibrillation in patients with an implantable cardioverter‐defibrillator and heart failure , 2010, European journal of heart failure.
[201] M. Rosenqvist,et al. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. , 2010, European heart journal.
[202] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.
[203] D. Tamborero,et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[204] Gerhard Hindricks,et al. Performance of a New Leadless Implantable Cardiac Monitor in Detecting and Quantifying Atrial Fibrillation Results of the XPECT Trial , 2010, Circulation. Arrhythmia and electrophysiology.
[205] L. Køber,et al. Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and Stroke , 2010, Circulation.
[206] F. Crea,et al. Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[207] P. Calder,et al. Omega-3 Fatty Acid Supplementation Does Not Reduce Risk of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2010, Circulation. Arrhythmia and electrophysiology.
[208] Elia Biganzoli,et al. Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.
[209] H. Wiste,et al. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy. , 2010, Heart rhythm.
[210] P. Kirchhof,et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. , 2011, Physiological reviews.
[211] A. Capucci,et al. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. , 2011, Journal of the American College of Cardiology.
[212] Robby Nieuwlaat,et al. Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey , 2012 .
[213] Rimm,et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.